The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

In patients with metastatic breast cancer (BC), the prevalence of brain metastases increased with each treatment line, rising the most among patients with hormone receptor (HR)–negative, human ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

As new drugs and new regimens come to the fore, we have to remember that most patients receive care from the general oncology ...

In patients with ERBB2-positive metastatic breast cancer (ERBB2+ MBC) and brain metastasis, more than half of deaths were due to central nervous system (CNS)–related causes; however, patients with CNS ...

This clinical trial will determine whether focused ultrasound can safely and effectively treat metastatic brain tumors when ...

Brain metastases arising from gynecologic cancers, including ovarian, endometrial and cervical malignancies, present unique diagnostic and therapeutic challenges. Although these metastatic events are ...

Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida, discusses a groundbreaking ...

People with the most common type of lung cancer whose disease has spread to the brain could be spared potentially harmful whole brain radiotherapy, according to new research published in The Lancet.